©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Translocation of Ricin A-chain into Proteoliposomes Reconstituted from Golgi and Endoplasmic Reticulum (*)

(Received for publication, June 20, 1995; and in revised form, July 28, 1995)

Aykut Bilge (1)(§) Concepcion V. Warner (2) Oliver W. Press (1) (2) (3)

From the  (1)Departments of Biological Structure and (2)Medicine, University of Washington, Seattle, Washington 98195 and the (3)Fred Hutchinson Cancer Research Center, Seattle, Washington 98104

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Translocation to the cytosol is an essential and rate-limiting step in the cytotoxicity of the potent plant toxin ricin. In an attempt to study the mechanism of ricin A-chain (RTA) translocation in a cell-free assay, we have partially purified Golgi and endoplasmic reticulum from Jurkat cells by discontinuous sucrose gradient fractionation. The membranes of the organelle fractions were solubilized by the addition of sodium cholate and reconstituted into proteoliposomes by dialyzing out the detergent. The resulting vesicles supported cell-free translocation of RTA (as assessed by an enzyme protection assay) at a rate which was linearly dependent on the concentration of the vesicle preparation. Ricin B-chain (RTB) neither translocated into the vesicles, nor increased the efficiency of RTA translocation. Liposomes prepared from purified phospholipids were not capable of supporting RTA translocation. Furthermore, protease treatment or concanavalin A adsorption of proteins from lysates prior to vesicle reconstitution resulted in abrogation of the translocation process, suggesting that the protein components of organelle membranes are required for RTA translocation. Reconstitution of translocation-competent proteoliposomes from detergent-solubilized membranes of endoplasmic reticulum- and Golgi-enriched fractions provides a convenient cell-free system to study the mechanism of RTA translocation.


INTRODUCTION

Ricin is a potent plant toxin which is used in the preparation of immunotoxins for the therapy of cancer and autoimmune and infectious diseases(1, 2) . It is composed of two polypeptide chains, the 32-kDa ribosome-inactivating chain, RTA, (^1)and the 33-kDa cell binding chain, RTB, which are linked to each other with a disulfide bond. Following endocytosis of ricin or immunotoxin by the target cell, RTA is transported to a cell compartment where it translocates to the cytosol and exerts its ribosome-inactivating effect (3) . RTA translocation is the rate-limiting step in the cytotoxicity of ricin and immunotoxins(4) . However, the intracellular site(s) and the mechanism of RTA translocation are poorly understood. Electron microscopic studies have shown that ricin is transported as far as the trans-Golgi network in the endocytic pathway(5) . Treatment of cells with brefeldin A, which disrupts the Golgi structure and blocks the connection between the endocytic pathway and the secretory pathway, results in the protection of cells from the toxic effects of ricin and other related plant and bacterial toxins such as modeccin, abrin, volkensin, viscumin, and Shiga toxin, but not of Diphtheria toxin, which is known to translocate to the cytosol from endosomes(6, 7) . Furthermore, brefeldin A protects cells from cholera toxin-induced elevation of intracellular cAMP(8) . These studies suggest that the retrograde transport of ricin and related toxins into proximal compartments of the secretory pathway such as the Golgi stacks and ER may be important for efficient cytotoxicity. Addition of a ER retrieval sequence, KDEL, onto the C-terminal end of RTA significantly increased the cytotoxicity of ricin (9) and RTA (10) lending credence to the concept that RTA translocates to the cytosol most efficiently from the ER. A recent study demonstrated that ricin translocation starts in the endosomes, but that translocation efficiency increases as the toxin is transported deeper into the endocytic pathway(11) .

A major obstacle for the study of ricin translocation in organelles deep in the internalization pathway, such as the Golgi stacks and ER, is death of cells before they accumulate sufficient concentrations of ricin to permit detection and experimentation. To circumvent this obstacle and to study the mechanism of translocation of RTA in these organelles, we developed a cell-free system in which we reconstituted translocation-competent proteoliposomes from detergent-solubilized membranes of Golgi- and ER-enriched fractions of Jurkat cells. Using this system, we studied the kinetics and the membrane requirements of RTA translocation and the effect of RTB on the translocation of RTA.


EXPERIMENTAL PROCEDURES

Reagents

RTA and RTB were purchased from Inland Laboratories (Austin, TX); Triton X-100, proteinase K, papain, and concanavalin A-Sepharose beads were from Sigma; ultrapure sodium cholate and Nonidet P-40 were from Calbiochem; immobilized protease Sg (a nonspecific protease) and immobilized papain were from Pierce; and phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol were from Avanti Polar Lipids Inc. (Alabaster, AL). A murine IgG(1) antibody recognizing the luminal domain of calnexin (AF8)(12) was a generous gift of Dr. Michael Brenner. A murine IgG(1) antibody targeting the luminal domain of the MPR (86f7) was kindly provided by Dr. Stuart Kornfeld. Murine IgG(1) was obtained by purification of monoclonal antibody DA 4.4 from ascitic fluid by affinity chromatography on Sepharose-staphylococcal protein A (Sigma). Jurkat cells were purchased from ATCC (Rockville, MD) and maintained as described previously(13) .

Radioiodination

RTA, RTB, mouse IgG, anti-MPR antibody, and anti-calnexin antibody were radioiodinated as described previously (13) . The specific activities of I-RTA and I-RTB were 14 and 70 Ci mmol, respectively.

Discontinuous Sucrose Gradient Fractionation

Fractionation methods were adapted from previous studies(14, 15) . All procedures were carried out on ice. 1 times 10^9 Jurkat cells were suspended in buffer A (50 mM TEA, 50 mM KOAc, 6 mM Mg(OAc)(2), 1 mM EDTA, 1 mM DTT, 0.5 mM phenylmethylsulfonyl fluoride) containing 0.25 M sucrose. The cells were homogenized with 30 strokes of a Dounce homogenizer (Kontes Inc., Moline, IL), and the nuclei and intact cells were removed by centrifuging at 10,000 times g for 5 min at 4 °C. The sucrose concentration of the supernatant was adjusted to 1.3 M by the addition of an appropriate amount of 2.5 M sucrose in buffer A and 4.5 ml of the resultant mixture placed in each of two Beckman ultraclear tubes. The 1.3 M sucrose/homogenate mixture was overlaid with 5 ml of 1.2 M sucrose in buffer A and with 3 ml of 0.8 M sucrose in buffer A. After ultracentrifugation for 2.5 h at 4 °C in a SW40 rotor at 94,000 times g, 1-ml fractions were collected and numbered from bottom to top. Fractions were then analyzed by enzyme assays and by electron microscopy as described previously(16) .

Enzyme and Protein Assays

The Golgi-specific enzyme, galactosyltransferase, was assayed by measuring the transfer of UDP-[U-^14C]galactose (Amersham Corp., Arlington Heights, IL) to ovalbumin (Sigma) as described previously(17) . The lysosomal enzyme, beta-galactosidase, was assayed using a colorimetric method (18) . The ER-associated enzyme, glucose-6-phosphatase, was assayed by measuring the release of inorganic phosphate from glucose 6-phosphate (Sigma)(17, 19) . Protein concentrations of the fractions were determined by bicinchoninic acid (BCA) assay (Pierce).

Reconstitution of Proteoliposomes

The reconstitution method was adapted from the procedure described by Nichitta and Blobel(20, 21) . Fractions 12 and 10 (Golgi) of the gradient were diluted to 0.5 M sucrose concentration by the addition of the appropriate amount of buffer B (0.25 M sucrose, 50 mM TEA, 1 mM DTT), and 3-ml aliquots were placed in tubes on ice. The pellet (fraction 1) was suspended in 1.1 ml of buffer B and supplemented by an equal amount of buffer D (0.2 M EDTA, 0.25 M sucrose, 50 mM TEA, 1 mM DTT) to strip ribosomes. Following 15-min incubation on ice, this sample was placed in tubes underlaid with 0.8 ml of buffer E (0.5 M sucrose, 50 mM TEA, 1 mM DTT). All the samples were then centrifuged in a Beckman TL 100.3 rotor at 140,000 times g for 1 h at 4 °C followed by resuspension of the pellets of each fraction in 230 µl of buffer F (0.4 M sucrose, 0.4 M KCl, 20 mM Tris, pH 7.6, 1.5 mM MgCl(2), 1 mM EDTA). The membranes were solubilized by the addition of sodium cholate and reconstituted into vesicles by dialysis as described previously(20, 21) . Vesicle concentrations were standardized prior to the performance of assays so that 250 µl of each preparation yielded an absorbance of 0.2 at 405 nm using a EL-310 model enzymelinked immunosorbent assay reader (Bio-Tek Instruments, Inc., Winooski, VT).

Topology Assays

Ten nanograms of I-IgG (DA 4.4), I-anti-MPR, and I-anti-calnexin were incubated with 30 µl of vesicles reconstituted from Golgi- and ER-enriched fractions at room temperature for 45 min. Each sample was then diluted with the addition of 100 µl of buffer G and centrifuged in an Airfuge A100/30 rotor (Beckman) for 10 min at 18 p.s.i. (110,000 times g). The radioactivity in the supernatant, and the pellet was determined by counting the samples with a Gamma 5500 (Beckman, Palo Alto, CA) counter and the vesicle (pellet)-associated counts/min was expressed as the percentage of the total.

ConA Chromatograpy

A 0.5-ml column of ConA-Sepharose was equilibrated with 10 column volumes of extraction buffer (0.8% sodium cholate in buffer F) and then loaded with 0.25 ml of cholate extract. The column was eluted at a flow rate of 0.25 ml/h, the eluate was concentrated to the original volume, and vesicles were reconstituted as described above.

Protease Digestion of Cholate Extract

125 µl of cholate extract was incubated with a mixture of 100 µl of immobilized papain and 100 µl of immobilized protease Sg at room temperature for 2, 18, and 42 h. Another 125 µl of cholate extract was incubated in the absence of protease beads for preparation of control vesicles. The protease beads were then removed by centrifugation at 1000 times g for 30 s, and vesicles were reconstituted from protease-digested and undigested cholate extracts as described above.

Preparation of Liposomes

Purified phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol were mixed to a total lipid concentration of 1 mM at a ratio of 75, 15, and 10%, respectively, and dried under Argon gas. The lipids were then resuspended in 1 ml of buffer G and sonicated for 10 min to form liposomes.

Translocation Assay

35 ng of I-RTA or I-RTB was incubated with or without reconstituted vesicles in 20 µl of buffer G at 37 °C for 1 h. The samples were then placed on ice and proteinase K, or papain was added to a final concentration of 1 unit/ml. Following incubation on ice for 75 min, 20 µl of 2 times Laemmli sample buffer (22) containing 10 mM phenylmethylsulfonyl fluoride was added, and the samples were ana-lyzed by SDS-PAGE, autoradiography and densitometry as described previously(13) .


RESULTS

Purification and Characterization of Golgi and ER

Jurkat cell homogenates were fractionated by centrifugation on a discontinuous sucrose gradient composed of 1.3, 1.2, and 0.8 M layers. Twelve fractions were collected (numbered from the bottom) and examined for their organelle content by electron microscopy and enzymatic analysis (Fig. 1). Relatively pure ER was recovered in fraction 1 as assessed by the presence of rough microsomes by electron microscopy (data not shown) and by the recovery of glucose-6-phosphatase activity. The microsome-bound ribosomes in this fraction were removed by washing with EDTA. Fraction 5 (1.3 M/1.2 M interface) was composed of lysosomes, mitochondria, and smooth ER by electron microscopic criteria (data not shown). Most of the lysosomal beta-galactosidase activity was contained in this fraction. Galactosyltransferase activity was recovered in fractions 10 and 11, indicating the presence of Golgi in these fractions. Fraction 10 (1.2 M/0.8 M interface) also contained some contaminating endosomes and surface membranes (data not shown). Although vesicular structures were abundant in fraction 12 by electron microscopy (data not shown), this fraction contained very little beta-galactosidase, glucose-6-phosphatase, or galactosyltransferase activity. A protein profile of the fractions is presented in Fig. 1.


Figure 1: Characterization of fractions obtained by discontinuous sucrose gradient centrifugation. Jurkat cells were disrupted with a Dounce homogenizer and fractionated on discontinuous sucrose gradients by ultracentrifugation. Harvested fractions were analyzed for their activities for galactosyltransferase (circle), a Golgi-specific enzyme; beta-galactosidase (box), a lysosome-specific enzyme; and glucose-6-phosphatase (bullet), an ER-associated enzyme (upper panel), as well as for protein concentrations () (bottom panel).



Topology of Reconstituted Proteoliposomes

The proteoliposome reconstitution system we have employed is identical to the system employed by Nicchitta and Blobel (20, 21) to study translocation of preprolactin. Using this methodology, the reconstituted vesicles produced are topologically restructured so that vectorially oriented membrane proteins are redistributed variably either in their native membrane orientations or in orientations opposite their native configurations (i.e. some luminal domains become abluminal). Such ``reconstituted'' proteoliposomes should permit ``retrograde'' translocation from the exterior to the interior of the vesicles. To confirm that the expected topological reorganization of the proteoliposome membranes had occurred, we tested the ability of I-labeled monoclonal antibodies specific for the lumenal domains of integral Golgi and ER membrane proteins, the mannose 6-phosphate receptor and calnexin, respectively, to bind to the exterior of the reconstituted vesicles. As shown in Fig. 2, specific binding of I-anti-MPR antibody confirmed the presence of the luminal domain of the mannose 6-phosphate receptor on the exterior surface of the vesicles reconstituted from Golgi-enriched fractions. Similarly, luminal determinants of calnexin were detected on the exterior surface of the vesicles reconstituted from ER-enriched fractions using I-anti-calnexin antibody (Fig. 2). A nonspecific mouse IgG(1) used as a control reagent bound minimally to the vesicles (Fig. 2).


Figure 2: Topology of the reconstituted vesicles. Vesicles reconstituted from Golgi- () and ER-enriched (box) fractions were incubated with I-IgG(1), I-anti-MPR, and I-anti-calnexin for 45 min at room temperature and then diluted with buffer G and pelleted. The vesicle associated antibody was determined by counting the radioactivity of the pellet and expressed as the percentage of the total. The total counts/min (bound + unbound) was 4,141 for I-IgG(1), 22,732 for I-anti-MPR and 9,782 for I-anti-calnexin. One of two concordant experiments is shown.



Translocation of RTA into Vesicles Reconstituted from Golgi- and ER-enriched Fractions

RTA Preincubated with Vesicles Reconstituted from Golgi- and ER-enriched Fractions Is Protected from Subsequent Papain Digestion

Vesicles were reconstituted identically from fractions 1 (ER-enriched), 10 (Golgi-enriched), and 12 and were standardized to the same concentration spectrophotometrically before utilizing in translocation assays. I-RTA was incubated with and without vesicles reconstituted from fractions 1 (ER), 10 (Golgi), and 12 for 1 h at 37 °C. Samples were then subjected to papain digestion on ice, and the degradation of I-RTA was assessed by SDS-PAGE and autoradiography. As shown in Fig. 3a, I-RTA was completely digested in the samples preincubated without vesicles or with vesicles reconstituted from fraction 12; however a quantity of I-RTA was protected from digestion in samples preincubated with vesicles reconstituted from Golgi- and ER-enriched fractions. Similar results were obtained with proteinase K digestion (data not shown).


Figure 3: Translocation of RTA into vesicles reconstituted from Golgi- and ER-enriched fractions. a,I-RTA was incubated with and without vesicles reconstituted from fractions 1 (ER), 10 (Golgi), and 12 and then digested with 1 unit/ml papain for 75 min on ice. Degradation was analyzed by SDS-PAGE and autoradiography. b,I-RTA was incubated with and without vesicles reconstituted from Golgi- and ER-enriched fractions in the presence and absence of 1% Nonidet P-40 and then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography as described above.



Protection from Papain Digestion Is Abrogated by Detergent Disruption of the Vesicles

I-RTA was incubated with and without vesicles reconstituted from Golgi- and ER-enriched fractions in the presence and absence of 1% Nonidet P-40 for 1 h at 37 °C. The samples were then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography. As shown in Fig. 3b, the integrity of the vesicles was required for protection from papain digestion, since I-RTA was completely digested when the vesicles were disrupted by detergents. Similar results were obtained when Nonidet P-40 was added after the incubation of the vesicles with RTA (data not shown). These data suggest that a quantity of I-RTA is protected from papain digestion by translocating into the vesicles reconstituted from Golgi- and ER-enriched fractions and that the vesicles reconstituted from fraction 12 are not competent for RTA translocation.

Linear Relationship between the Amount of Translocated RTA and the Concentration of the Vesicle Preparation

I-RTA was incubated with and without vesicles at the dilutions indicated in Fig. 4in the presence and absence of 1% Triton X-100 for 1 h at 37 °C. The samples were then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography. As shown in Fig. 4, the amount of I-RTA that translocated was dependent on the concentration of the vesicle preparation. Dilution of the vesicles resulted in lesser protection from papain digestion (upper panel). Densitometric analysis of the lanes revealed that there was a linear relationship between the amount of translocated RTA and the concentration of the vesicles (lower panel).


Figure 4: Effect of the concentration of vesicles on the translocation of RTA. I-RTA was incubated with and without vesicles reconstituted from ER-enriched fractions at the indicated dilutions and then digested with 1 unit/ml papain for 75 min on ice. The concentrations of vesicle suspensions (Dilution 1) were standardized spectrophotometrically so that 250 µl of each vesicle preparation possessed an absorbance of 0.2 at 405 nm. Degradation was analyzed by SDS-PAGE and autoradiography (upper panel). The amount of translocated RTA at each dilution was determined by densitometric analysis of the lanes and plotted (lower panel).



Effect of Incubation Time on the Translocation of RTA into Reconstituted Vesicles

I-RTA was incubated with and without vesicles for 0.5, 1, 2, and 4 h time points at 37 °C. The samples were then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography (Fig. 5, upper panel). The lanes from the autoradiographs of two experiments were analyzed by densitometry and plotted as shown in the lower panel of Fig. 5. The results indicate that the amount of RTA that translocates increases with the incubation time, reaching a plateau of approximately 25% of total RTA in 1 h.


Figure 5: Effect of incubation time on the translocation of RTA. I-RTA was incubated with and without vesicles for the indicated times and then digested with 1 unit/ml papain for 75 min on ice. Degradation was analyzed by SDS-PAGE and autoradiography. The autoradiographs of two separate experiments are shown (upper panel). The amount of the translocated RTA at each time point was determined by densitometric analysis of the lanes and plotted (lower panel). (circle, experiment 1; bullet, experiment 2).



Liposomes Prepared from Purified Phospholipids Do Not Support RTA Translocation

Liposomes were prepared from purified phosphatidylcholine, phosphatidylethanolamine, and phosphatidylinositol and then tested for RTA translocation competence. I-RTA was incubated with and without vesicles at the indicated dilutions for 1 h at 37 °C. The samples were then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography. I-RTA was completely digested even in the presence of vesicles, suggesting that the protein component of the Golgi or ER fractions is required for the translocation of RTA (data not shown).

Removal of the Protein Components of Golgi and ER Vesicles Abrogates RTA Translocation

To further investigate the role of the protein constitutents of Golgi and ER proteoliposomes in the translocation process, we treated cholate extracts with immobilized papain and protease Sg (a nonspecific protease) for 2, 18 and 42 h prior to vesicle reconstitution. After removal of the immobilized proteases, vesicles were reconstituted and tested for their competence for RTA translocation. As shown in Fig. 6(upper three panels), vesicles reconstituted from Golgi-enriched fractions after 2 h of protease treatment retained translocation competence, whereas longer protease treatments completely abrogated the ability of reconstituted vesicles to support translocation. Similar conclusions were reached using vesicles reconstituted from ER-enriched fractions, although translocation was only reduced by 47% after 42 h of incubation with immobilized proteases (data not shown).


Figure 6: Effect of protein depletion on translocation of RTA. I-RTA was incubated with vesicles reconstituted from protease-treated cholate extracts (upper three panels) or ConA-adsorbed cholate extracts (lower panel) of the Golgi-enriched fraction, digested with proteinase K, and analyzed by SDS-PAGE and autoradiography. Similar results were obtained in experiments using ER-enriched fractions for vesicle reconstitution (data not shown).



An alternative protein depletion approach corroborated the conclusions derived from the protease experiments. Cholate extracts of Golgi- and ER-enriched fractions were passed through ConA columns to deplete glycoprotein constituents prior to vesicle reconstitution. This method of protein depletion also abrogated the translocation competence of the subsequently reconstituted vesicles as illustrated in Fig. 6(lower panel).

RTB Does Not Translocate into Reconstituted Vesicles

RTB, the cell binding domain of ricin, is a potentiator of RTA immunotoxins which is postulated to facilitate RTA translocation (23, 24, 25, 26, 27) . We tested the ability of RTB to translocate into reconstituted vesicles. I-RTB was incubated with and without vesicles reconstituted from Golgi-enriched fractions in the presence and absence of 1% Nonidet P-40 for 1 h at 37 °C. The samples were then subjected to papain digestion and analyzed by SDS-PAGE and autoradiography. RTB did not translocate into the reconstituted vesicles, but was completely digested by papain (Fig. 7). A similar result was obtained from an experiment in which vesicles reconstituted from the ER-enriched fraction were used (data not shown).


Figure 7: Inability of RTB to translocate into reconstituted vesicles. I-RTB was incubated with and without vesicles reconstituted from Golgi-enriched fractions in the presence and absence of 1% Nonidet P-40 and then digested with 1 unit/ml papain for 75 min. Degradation of I-RTB was analyzed by SDS-PAGE and autoradiography. Similar results were obtained using proteoliposomes reconstituted from ER-enriched membranes (data not shown).



RTB Protects RTA from Enzyme Digestion

We tested the effect of RTB on the translocation of RTA into reconstituted vesicles. I-RTA was incubated with and without vesicles reconstituted from the ER-enriched fraction in the presence and absence of unlabeled RTB for 1 h at 37 °C. The samples were then subjected to proteinase K digestion and analyzed by SDS-PAGE, autoradiography, and densitometry. The results are shown in Fig. 8. In the presence of vesicles, I-RTA was protected from digestion by proteinase K (lane C). Addition of RTB in the absence of vesicles also resulted in the protection of I-RTA from proteolysis (lane F). The presence of RTB together with vesicles resulted in a protection that was not significantly greater than the sum of the protection obtained in the presence of either RTB or vesicles alone (lane G) as assessed by densitometric analysis of the lanes in six separate experiments (data not shown). Nonidet P-40 abrogated the protective effect of vesicles but not of RTB on the digestion of RTA. (lanes D and H). These data suggest that RTB is not essential for effective translocation of RTA.


Figure 8: Effect of RTB on the translocation of RTA into reconstituted vesicles. I-RTA was incubated with and without vesicles reconstituted from ER-enriched fractions in the presence and absence of 0.1 µg of unlabeled RTB and then digested with 1 unit/ml proteinase K. Degradation of I-RTA was analyzed by SDS-PAGE, autoradiography, and densitometry. Similar results were obtained using proteoliposomes reconstituted from Golgi-enriched membranes (data not shown).




DISCUSSION

Several independent lines of investigation have suggested that most plant and bacterial toxins, including ricin, translocate to the cytosol most efficiently from organelles deep in the internalization pathway (e.g. the trans-Golgi region or endoplasmic reticulum). Ricin has been demonstrated in the trans-Golgi network by electron microscopic studies(5, 6) . Furthermore, brefeldin A treatment has protected the cells from the detrimental effects of most related bacterial and plant toxins, suggesting that the organelles of the secretory pathway (Golgi and ER) might be involved in the action of these toxins(6, 7, 8) . The increased cytotoxicity of the KDEL-modified RTA has provided additional evidence for the trafficking of RTA to Golgi and ER for efficient translocation (9, 10) . Unfortunately, it has been very difficult to study toxin translocation from the Golgi or ER, because the extreme potency of these reagents results in cell death before appreciable concentrations of toxin accumulate in these compartments. For example, it has been estimated that one ricin molecule can inactivate 1500 ribosomes per minute and that this rate is sufficient to kill a cell(28, 29) . Although the efficiency of the translocation process is not known with certainty, it appears plausible to assume that most standard assays are insufficiently sensitive to detect toxin concentrations capable of causing irreversible cytotoxicity. Consequently, we have developed an in vitro translocation assay based on proteoliposomes reconstituted from purified Golgi- or ER-enriched membranes by adapting methodology which has proven indispensable for the study of translocation of secretory proteins from ribosomes to the ER lumen(20, 21, 30) . As demonstrated in the present study, translocation-competent proteoliposomal vesicles from detergent solubilized membranes of Golgi- and ER-enriched fractions provide convenient cell-free systems for the study of RTA translocation.

Our experiments show that RTA is able to translocate efficiently into reconstituted vesicles derived from either Golgi- or ER-enriched fractions of Jurkat cells in a manner linearly dependent on the vesicle concentration. The kinetics of the translocation process show that the amount of RTA that translocates increases linearly for 1 h and then plateaus. It appears likely that the cessation of translocation after 1 h in this reconstituted system is due to depletion of an endogenous (organelle membrane-derived) energy source that drives the translocation machinery. In their recent study of ricin translocation across endosomal membranes, Beaumelle et al.(11) showed that ricin translocation in endosomes is ATP-dependent and stops after 30 min unless exogenous ATP is added. The difference in the duration of translocation without exogenous ATP between the present study and that of Beaumelle et al.(11) may reflect inherent differences in the distribution of energy-generating systems between Golgi, ER and endosomes.

RTB is known to augment the toxicity of RTA(23, 24, 25, 26, 27) , although the mechanism underlying this potentiating effect is poorly understood. It has long been postulated that RTB facilitates translocation of RTA in a manner analagous to that proposed for diphtheria toxin B-chain which is believed to insert into endosomal membranes at acidic pH values, forming a channel for A-chain translocation to the cytosol(23, 24, 26, 31) . Alternatively, Lord and co-workers (32, 33) have suggested that RTB may subserve an intracellular shuttling function by binding to intracellular galactose residues expressed by molecules along the internalization pathway, thereby ``ratcheting'' RTA along the endocytic pathway to its translocation site. Finally, recent studies have shown that RTB protects RTA from degradation by endosomal and lysosomal proteolytic enzymes and may thereby enhance the cytotoxicity of RTA(13) .

In the present study, we tested the ability of RTB to translocate into reconstituted Golgi and ER vesicles and its effect on the translocation of RTA. RTB neither translocated by itself, nor augmented the amount of RTA that translocated into reconstituted vesicles. In contrast to our findings with reconstituted Golgi and ER proteoliposomes, Beaumelle et al.(11) found that RTB was able to translocate across the membranes of endosomes purified by gradient centrifugation. The discrepancy between our findings and those of Beaumelle et al.(11) may reflect methodologic differences or could result from structural differences in the organelles studied. The membrane component which facilitates translocation of RTB in endosomes may not exist in Golgi and ER, or alternatively, it could be lost or inactivated in the reconstitution process.

One of the most active areas of current research in cell biology concerns investigations into the mechanisms involved in protein transport across biological membranes. Studies of peptide (34, 35) and nascent chain (36) translocation across membranes of the endoplasmic reticulum, mitochondria(37) , and bacterial surface membranes (38) have demonstrated that protein channels exist which facilitate transmembrane protein transport (e.g. ``translocon'' protein channels for nascent secretory proteins (36, 39) and the ``TAP transporter'' channels (34, 35) for targeting cytosolic peptides to class I major histocompatibility complex molecules). Since our present studies indicate that liposomes prepared from purified phospholipids or from cellular fractions depleted in membrane glycoproteins are unable to support the translocation of RTA, it appears likely that proteinaceous constitutents of Golgi and ER membranes play an integral role in the translocation of ricin A-chain and other toxins. As suggested by Wales et al.(10) , it is conceivable that RTA utilizes previously identified translocation components of the ER (i.e. the translocon complex) in a retrograde direction, from lumen to the cytosol. Alternatively, heretofore unrecognized protein channels may be employed for toxin translocation.

Recent studies by Theuer et al.(40, 41) employing an in vitro translation/translocation system suggest that a truncated form of Pseudomonas exotoxin (PE37) can insert into the membrane of canine pancreatic microsomes if guided by the preprocecropin signal sequence, but that a ``stop-transfer'' sequence in domain II of the toxin arrests translocation and releases the toxin from the microsomes before it can transfer into the lumen of the microsomes. Our data suggest that a less complicated interaction occurs between ricin A-chain and Golgi/ER proteoliposomes and that full translocation of the molecule occurs in the absence of a signal sequence and without interruption by a stop transfer sequence. We believe that translocation-competent proteoliposomes such as those described in this report will prove to be as useful for the molecular dissection of the structural components involved in the translocation of plant and bacterial toxins as they have been in studying the translocation of secretory proteins(20, 21, 30) .


FOOTNOTES

*
This work was supported by National Institutes of Health Grant R01-CA-55596. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
To whom correspondence should be addressed: University of Washington, Dept. of Biological Structure, P. O. Box 357420, Seattle, WA 98195. Tel.: 206-543-7140; Fax: 206-543-1524.

(^1)
The abbreviations used are: RTA, ricin A-chain; RTB, ricin B-chain; ConA, concanavalin A; ER, endoplasmic reticulum; DTT, dithiothreitol; MPR, mannose 6-phosphate receptor; TEA, triethanolamine; PAGE, polyacrylamide gel electrophoresis.


REFERENCES

  1. Press, O. W. (1991) Biotherapy 3,65-76 [Medline] [Order article via Infotrieve]
  2. Vitetta, E. S., and Thorpe, P. E. (1991) Semin. Cell Biol. 2,47-58 [Medline] [Order article via Infotrieve]
  3. van Deurs, B., Sandvig, K., Petersen, O. W., and Olsnes, S. (1990) Trafficking of Bacterial Toxins (Saelinger, C. B., ed) pp. 91-119, CRC Press, Inc., Boca Raton, FL
  4. Hudson, T. H., and Neville, D. M., Jr. (1987) J. Biol. Chem. 262,16484-16494 [Abstract/Free Full Text]
  5. van Deurs, B., Sandvig, K., Petersen, O. W., Olsnes, S., Simons, K., and Griffiths, G. (1988) J. Cell Biol. 106,253-267 [Abstract]
  6. Sandvig, K., Prydz, K., Hansen, S. H., and van Deurs, B. (1991) J. Cell Biol. 115,971-981 [Abstract]
  7. Hudson, T. H., and Grillo, F. G. (1991) J. Biol. Chem. 266,18586-18592 [Abstract/Free Full Text]
  8. Nambiar, M. P., Oda, T., Chen, C., Kuwazuru, Y., and Wu, H. C. (1993) J. Cell. Physiol. 154,222-228 [Medline] [Order article via Infotrieve]
  9. Wales, R., Chaddock, J. A., Roberts, L. M., and Lord, J. M. (1992) Exp. Cell Res. 203,1-4 [Medline] [Order article via Infotrieve]
  10. Wales, R., Roberts, L. M., and Lord, J. M. (1993) J. Biol. Chem. 268,23986-23990 [Abstract/Free Full Text]
  11. Beaumelle, B., Alami, M., and Hopkins, C. R. (1993) J. Biol. Chem. 268,23661-23669 [Abstract/Free Full Text]
  12. Hochstenbach, F., David, V., Watkins, S., and Brenner, M. B. (1992) Proc. Natl. Acad. Sci. U. S. A. 89,4734-4738 [Abstract]
  13. Bilge, A., Howell-Clark, J., Ramakrishnan, S., and Press, O. W. (1994) Ther. Immunol. 1,197-204 [Medline] [Order article via Infotrieve]
  14. Balch, W. E., Dunphy, W. G., Braell, W. A., and Rothman, J. E. (1984) Cell 39,405-416 [Medline] [Order article via Infotrieve]
  15. Walter, P., and Blobel, G. (1983) Methods Enzymol. 96,84-93 [Medline] [Order article via Infotrieve]
  16. Geissler, F., Anderson, S. K., Venkatesan, P., and Press, O. (1992) Cancer Res. 52,2907-2915 [Abstract]
  17. Beaufay, H., Amar-Costesec, A., Feytmans, E., Thines-Sempoux, D., Wibo, M., Robbi, M., and Berthet, J. (1974) J. Cell Biol. 61,188-200 [Abstract/Free Full Text]
  18. Rome, L. H., Garvin, A. J., Alietta, M. M., and Neufeld, E. F. (1979) Cell 17,143-153 [CrossRef][Medline] [Order article via Infotrieve]
  19. Ames, B. N. (1966) Methods Enzymol. 8,115-118
  20. Nicchitta, C. V., and Blobel, G. (1990) Cell 60,259-269 [Medline] [Order article via Infotrieve]
  21. Nicchitta, C., Migliaccio, G., and Blobel, G. (1991) Methods Cell Biol. 34,263-285 [Medline] [Order article via Infotrieve]
  22. Laemmli, U. K. (1970) Nature 227,680-685 [Medline] [Order article via Infotrieve]
  23. McIntosh, D. P., Edwards, D. C., Cumber, A. J., Parnell, G. D., Dean, C. J., Ross, W. C. J., and Forrester, J. A. (1983) FEBS Lett. 164,17-20 [CrossRef][Medline] [Order article via Infotrieve]
  24. Youle, R. J., and Neville, D. M. Jr. (1982) J. Biol. Chem. 257,1598-1601 [Free Full Text]
  25. Vitetta, E. S., Cushley, W., and Uhr, J. W. (1983) Proc. Natl. Acad. Sci. U. S. A. 80,6332-6335 [Abstract]
  26. Vitetta, E. S. (1986) J. Immunol. 136,1880-1887 [Abstract/Free Full Text]
  27. Wawrzynczak, E. J., Drake, A. F., Watson, G. J., Thorpe, P. E., and Vitetta, E. S. (1988) Biochim. Biophys. Acta 971,55-62 [Medline] [Order article via Infotrieve]
  28. Carrasco, L., Fernandez-Puentes, C., and Vazquez, D. (1975) Eur. J. Biochem. 54,499-503 [Abstract]
  29. Eiklid, K., Olsnes, S., and Pihl, A. (1980) Exp. Cell Res. 126,321-326 [Medline] [Order article via Infotrieve]
  30. Görlich, D., Hartmann, E., Prehn, S., and Rapoport, T. A. (1992) Nature 357,47-52 [CrossRef][Medline] [Order article via Infotrieve]
  31. London, E. (1992) Biochim. Biophys. Acta 1113,25-51 [Medline] [Order article via Infotrieve]
  32. Newton, D. L., Wales, R., Richardson, P. T., Walbridge, S., Saxena, S. K., Ackerman, E. J., Roberts, L. M., Lord, J. M., and Youle, R. J. (1992) J. Biol. Chem. 267,11917-11922 [Abstract/Free Full Text]
  33. Lord, J. M., Wales, R., Pitcher, C., and Roberts, L. M. (1992) Biochem. Soc. Trans. 20,734-738 [Medline] [Order article via Infotrieve]
  34. Monaco, J. J. (1992) Immunol. Today 13,173-179 [CrossRef][Medline] [Order article via Infotrieve]
  35. Androlewicz, M. J., and Cresswell, P. (1994) Immunity 1,7-14 [Medline] [Order article via Infotrieve]
  36. Nunnari, J., and Walter, P. (1992) Curr. Opin. Cell Biol. 4,573-580 [Medline] [Order article via Infotrieve]
  37. Wienhues, U., and Neupert, W. (1992) Bioessays 14,17-23 [Medline] [Order article via Infotrieve]
  38. Swidersky, U. E., Hoffshulte, H. K., and Müller, M. (1990) EMBO J. 9,1777-1785 [Abstract]
  39. Gilmore, R. (1993) Cell 75,589-592 [Medline] [Order article via Infotrieve]
  40. Theuer, C., Kasturi, S., and Pastan, I. (1994) Biochemistry 33,5894-5900 [Medline] [Order article via Infotrieve]
  41. Theuer, C. P., Buchner, J., Fitzgerald, D., and Pastan, I. (1993) Proc. Natl. Acad. Sci. U. S. A. 90,7774-7778 [Abstract/Free Full Text]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.